{"id":"https://openalex.org/W2951753472","doi":"https://doi.org/10.1097/01.hs9.0000561788.84381.2e","title":"S877 SAFETY AND CLINICAL ACTIVITY OF AMV564, A CD33/CD3 T\u2010CELL ENGAGER, IN PATIENTS WITH RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA (AML): UPDATED RESULTS FROM THE PHASE 1 FIRST\u2010IN\u2010HUMAN TRIAL","display_name":"S877 SAFETY AND CLINICAL ACTIVITY OF AMV564, A CD33/CD3 T\u2010CELL ENGAGER, IN PATIENTS WITH RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA (AML): UPDATED RESULTS FROM THE PHASE 1 FIRST\u2010IN\u2010HUMAN TRIAL","publication_year":2019,"publication_date":"2019-06-01","ids":{"openalex":"https://openalex.org/W2951753472","doi":"https://doi.org/10.1097/01.hs9.0000561788.84381.2e","mag":"2951753472"},"language":"en","primary_location":{"id":"doi:10.1097/01.hs9.0000561788.84381.2e","doi":"https://doi.org/10.1097/01.hs9.0000561788.84381.2e","is_oa":true,"landing_page_url":"https://doi.org/10.1097/01.hs9.0000561788.84381.2e","pdf_url":null,"source":{"id":"https://openalex.org/S4210211592","display_name":"HemaSphere","issn_l":"2572-9241","issn":["2572-9241"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","norway-1","oarl","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"HemaSphere","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1097/01.hs9.0000561788.84381.2e","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5105528827","display_name":"Peter Westervelt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I204465549","display_name":"Washington University in St. Louis","ror":"https://ror.org/01yc7t268","country_code":"US","type":"education","lineage":["https://openalex.org/I204465549"]},{"id":"https://openalex.org/I4390039297","display_name":"Abramson Cancer Center","ror":"https://ror.org/01hvpjq66","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210143392","https://openalex.org/I4390039297"]},{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"P. Westervelt","raw_affiliation_strings":["Washington University School of Medicine Saint Louis MO","Abramson Cancer Center, University of Pennsylvania, Philadelphia, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Washington University School of Medicine Saint Louis MO","institution_ids":["https://openalex.org/I204465549"]},{"raw_affiliation_string":"Abramson Cancer Center, University of Pennsylvania, Philadelphia, United States","institution_ids":["https://openalex.org/I4390039297","https://openalex.org/I79576946"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012863731","display_name":"Gail J. Roboz","orcid":"https://orcid.org/0000-0002-0384-3658","observed_orcids":["https://orcid.org/0000-0002-0384-3658"]},"institutions":[{"id":"https://openalex.org/I205783295","display_name":"Cornell University","ror":"https://ror.org/05bnh6r87","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295"]},{"id":"https://openalex.org/I4387153466","display_name":"Weill Cornell Medicine","ror":"https://ror.org/02r109517","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295","https://openalex.org/I4387153466"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"G.J. Roboz","raw_affiliation_strings":["Weill Cornell Medicine Weill Medical College of Cornell University New York NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Weill Cornell Medicine Weill Medical College of Cornell University New York NY","institution_ids":["https://openalex.org/I205783295","https://openalex.org/I4387153466"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015101485","display_name":"J\u00f6rge E. Cortes","orcid":"https://orcid.org/0000-0002-8636-1071","observed_orcids":["https://orcid.org/0000-0002-8636-1071"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J.E. Cortes","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center Houston TX","MD Anderson Cancer Center, University of Texas, Houston, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center Houston TX","institution_ids":["https://openalex.org/I1343551460"]},{"raw_affiliation_string":"MD Anderson Cancer Center, University of Texas, Houston, United States","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025780450","display_name":"Jessica Kaplan Altman","orcid":"https://orcid.org/0000-0003-1987-1896","observed_orcids":["https://orcid.org/0000-0003-1987-1896"]},"institutions":[{"id":"https://openalex.org/I111979921","display_name":"Northwestern University","ror":"https://ror.org/000e0be47","country_code":"US","type":"education","lineage":["https://openalex.org/I111979921"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J.K. Altman","raw_affiliation_strings":["Northwestern University Chicago IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Northwestern University Chicago IL","institution_ids":["https://openalex.org/I111979921"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009149109","display_name":"Vivian G. Oehler","orcid":"https://orcid.org/0000-0002-1630-4151","observed_orcids":["https://orcid.org/0000-0002-1630-4151"]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"V.G. Oehler","raw_affiliation_strings":["Fred Hutchinson Cancer Research Center Seattle WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fred Hutchinson Cancer Research Center Seattle WA","institution_ids":["https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082915839","display_name":"Meixiao Long","orcid":"https://orcid.org/0000-0002-0820-5612","observed_orcids":["https://orcid.org/0000-0002-0820-5612"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]},{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. Long","raw_affiliation_strings":["Ohio State University Columbus OH","Memorial Sloan-Kettering Cancer Center, New York, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ohio State University Columbus OH","institution_ids":["https://openalex.org/I52357470"]},{"raw_affiliation_string":"Memorial Sloan-Kettering Cancer Center, New York, United States","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111926111","display_name":"Hagop M. Kantarjian","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"H.M. Kantarjian","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center Houston TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center Houston TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029241088","display_name":"S. Lee","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I205783295","display_name":"Cornell University","ror":"https://ror.org/05bnh6r87","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295"]},{"id":"https://openalex.org/I2801680663","display_name":"Asan Medical Center","ror":"https://ror.org/03s5q0090","country_code":"KR","type":"healthcare","lineage":["https://openalex.org/I2801680663","https://openalex.org/I4210167194"]},{"id":"https://openalex.org/I40542001","display_name":"University of Ulsan","ror":"https://ror.org/02c2f8975","country_code":"KR","type":"education","lineage":["https://openalex.org/I40542001"]},{"id":"https://openalex.org/I4387153466","display_name":"Weill Cornell Medicine","ror":"https://ror.org/02r109517","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295","https://openalex.org/I4387153466"]}],"countries":["KR","US"],"is_corresponding":false,"raw_author_name":"S. Lee","raw_affiliation_strings":["Weill Cornell Medicine Weill Medical College of Cornell University New York NY","Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic Of"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Weill Cornell Medicine Weill Medical College of Cornell University New York NY","institution_ids":["https://openalex.org/I205783295","https://openalex.org/I4387153466"]},{"raw_affiliation_string":"Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic Of","institution_ids":["https://openalex.org/I2801680663","https://openalex.org/I40542001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110045124","display_name":"Tae Hyung Han","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"T.H. Han","raw_affiliation_strings":["Amphivena Therapeutics Inc South San Francisco CA United States","Massachussetts General Hospital, Harvard Medical School, Boston"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amphivena Therapeutics Inc South San Francisco CA United States","institution_ids":[]},{"raw_affiliation_string":"Massachussetts General Hospital, Harvard Medical School, Boston","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078017441","display_name":"Jeanmarie Guenot","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. Guenot","raw_affiliation_strings":["Amphivena Therapeutics Inc South San Francisco CA United States","MD Anderson Cancer Center, University of Texas, Houston, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amphivena Therapeutics Inc South San Francisco CA United States","institution_ids":[]},{"raw_affiliation_string":"MD Anderson Cancer Center, University of Texas, Houston, United States","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040539933","display_name":"Eric Jay Feldman","orcid":"https://orcid.org/0009-0006-8191-7698","observed_orcids":["https://orcid.org/0009-0006-8191-7698"]},"institutions":[{"id":"https://openalex.org/I2801680663","display_name":"Asan Medical Center","ror":"https://ror.org/03s5q0090","country_code":"KR","type":"healthcare","lineage":["https://openalex.org/I2801680663","https://openalex.org/I4210167194"]},{"id":"https://openalex.org/I40542001","display_name":"University of Ulsan","ror":"https://ror.org/02c2f8975","country_code":"KR","type":"education","lineage":["https://openalex.org/I40542001"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"E.J. Feldman","raw_affiliation_strings":["Amphivena Therapeutics Inc South San Francisco CA United States","Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic Of"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amphivena Therapeutics Inc South San Francisco CA United States","institution_ids":[]},{"raw_affiliation_string":"Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic Of","institution_ids":["https://openalex.org/I2801680663","https://openalex.org/I40542001"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5065066309","display_name":"John F. DiPersio","orcid":"https://orcid.org/0000-0002-0429-3133","observed_orcids":["https://orcid.org/0000-0002-0429-3133"]},"institutions":[{"id":"https://openalex.org/I204465549","display_name":"Washington University in St. Louis","ror":"https://ror.org/01yc7t268","country_code":"US","type":"education","lineage":["https://openalex.org/I204465549"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J.F. DiPersio","raw_affiliation_strings":["Washington University School of Medicine Saint Louis MO"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Washington University School of Medicine Saint Louis MO","institution_ids":["https://openalex.org/I204465549"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":14,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2480,"currency":"USD","value_usd":2480},"apc_paid":{"value":2480,"currency":"USD","value_usd":2480},"fwci":null,"has_fulltext":false,"cited_by_count":9,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"3","issue":"S1","first_page":"393","last_page":"394"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9726999998092651,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9726999998092651,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.004800000227987766,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":0.00430000014603138,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bispecific-t-cell-engagers","display_name":"bispecific T-cell engagers","score":0.8809999823570251},{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.8899999856948853},{"id":"https://openalex.org/keywords/relapsed-refractory-aml","display_name":"relapsed/refractory AML","score":0.9710000157356262},{"id":"https://openalex.org/keywords/safety-and-tolerability","display_name":"safety and tolerability","score":0.8820000290870667},{"id":"https://openalex.org/keywords/antileukemic-activity","display_name":"antileukemic activity","score":0.8199999928474426},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.6420000195503235},{"id":"https://openalex.org/keywords/cytokine-changes","display_name":"cytokine changes","score":0.6420000195503235},{"id":"https://openalex.org/keywords/t-cell-phenotyping","display_name":"T cell phenotyping","score":0.8050000071525574},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.5809999704360962}],"concepts":[{"id":"https://openalex.org/C176290653","wikidata":"https://www.wikidata.org/wiki/Q21114013","display_name":"CD33","level":4,"score":0.7237402200698853},{"id":"https://openalex.org/C196166836","wikidata":"https://www.wikidata.org/wiki/Q902926","display_name":"Immunophenotyping","level":3,"score":0.6608391404151917},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5528436303138733},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.5353930592536926},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.46052059531211853},{"id":"https://openalex.org/C2779282312","wikidata":"https://www.wikidata.org/wiki/Q1956561","display_name":"Myeloid","level":2,"score":0.45153456926345825},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.44955241680145264},{"id":"https://openalex.org/C2780850621","wikidata":"https://www.wikidata.org/wiki/Q3961647","display_name":"Cytokine release syndrome","level":5,"score":0.430339515209198},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.4225253462791443},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.4194398522377014},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.38705122470855713},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3848762512207031},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3724035620689392},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.2580510973930359},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.22564947605133057},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.219776451587677},{"id":"https://openalex.org/C553184892","wikidata":"https://www.wikidata.org/wiki/Q1141429","display_name":"Flow cytometry","level":2,"score":0.21397611498832703},{"id":"https://openalex.org/C28328180","wikidata":"https://www.wikidata.org/wiki/Q48196","display_name":"Stem cell","level":2,"score":0.18755388259887695},{"id":"https://openalex.org/C10205521","wikidata":"https://www.wikidata.org/wiki/Q4035578","display_name":"CD34","level":3,"score":0.15119722485542297},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.12308946251869202},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C3875195","wikidata":"https://www.wikidata.org/wiki/Q5099363","display_name":"Chimeric antigen receptor","level":4,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1097/01.hs9.0000561788.84381.2e","doi":"https://doi.org/10.1097/01.hs9.0000561788.84381.2e","is_oa":true,"landing_page_url":"https://doi.org/10.1097/01.hs9.0000561788.84381.2e","pdf_url":null,"source":{"id":"https://openalex.org/S4210211592","display_name":"HemaSphere","issn_l":"2572-9241","issn":["2572-9241"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","norway-1","oarl","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"HemaSphere","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1097/01.hs9.0000561788.84381.2e","doi":"https://doi.org/10.1097/01.hs9.0000561788.84381.2e","is_oa":true,"landing_page_url":"https://doi.org/10.1097/01.hs9.0000561788.84381.2e","pdf_url":null,"source":{"id":"https://openalex.org/S4210211592","display_name":"HemaSphere","issn_l":"2572-9241","issn":["2572-9241"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","norway-1","oarl","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"HemaSphere","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4206277904","https://openalex.org/W2899277149","https://openalex.org/W2899183123","https://openalex.org/W2887967524","https://openalex.org/W3095842680","https://openalex.org/W2955338620","https://openalex.org/W2987573142","https://openalex.org/W4255397938","https://openalex.org/W4396596589","https://openalex.org/W2899502645"],"abstract_inverted_index":{"Background:":[0],"AMV564":[1,22,53,180,211,439,485,500],"is":[2,132,181,222,486],"a":[3,139,144,165,193,236,271,300,340,445,496,502,507],"novel":[4],"bivalent,":[5],"bispecific":[6],"(2:2)":[7],"CD33/CD3":[8],"targeted":[9],"immunotherapy":[10],"that":[11],"binds":[12],"both":[13,479],"CD33":[14,38,70],"and":[15,30,41,45,60,73,105,119,124,172,212,220,285,319,356,427,469,481,488,513],"the":[16,102,308,515],"invariant":[17],"CD3\u03b5":[18],"on":[19],"T\u2010cell":[20,34,476,493,520],"receptors.":[21],"creates":[23],"an":[24,133],"immune":[25],"synapse":[26],"between":[27],"CD33\u2010expressing":[28],"cells":[29,82,123,126],"T":[31,48,81,122],"cells,":[32,40],"initiating":[33],"directed":[35],"lysis":[36],"of":[37,47,65,80,96,109,112,116,121,239,310,381,391,403,410,435,448,460,475],"expressing":[39],"inducing":[42],"activation,":[43],"differentiation":[44],"proliferation":[46],"cells.":[49],"In":[50],"preclinical":[51],"studies,":[52],"eliminated":[54],"myeloid":[55,125],"blasts":[56],"with":[57,76,138,154,235,270,423,444,455,473,506],"picomolar":[58],"potency":[59],"demonstrated":[61],"broad":[62],"activity":[63,108,491],"independent":[64],"cytogenetic":[66],"or":[67,169,208,329,360,413],"molecular":[68],"abnormalities,":[69],"expression":[71],"level,":[72],"disease":[74,206],"stage,":[75],"no":[77,173,357],"nonspecific":[78],"activation":[79,477],"(Reusch":[83],"U":[84],"et":[85],"al.":[86],"Clin":[87],"Cancer":[88],"Res":[89],"2016;":[90],"22:5829\u201338).":[91],"Aims:":[92],"The":[93,148,366],"primary":[94],"objectives":[95],"this":[97,311],"study":[98,137],"are":[99,127,199,215],"to":[100,201,254,457],"characterize":[101],"safety,":[103],"tolerability,":[104],"preliminary":[106],"anti\u2010leukemic":[107,490],"AMV564.":[110],"Evaluation":[111],"pharmacokinetics":[113],"(PK),":[114],"assessment":[115],"cytokine":[117,213],"changes,":[118],"immunophenotyping":[120,221],"secondary":[128,261],"objectives.":[129],"Methods:":[130],"This":[131],"ongoing":[134],"Phase":[135],"1":[136,281,303,350,421,428],"3+3":[140],"dose\u2010escalation":[141],"followed":[142],"by":[143,183,217,224],"dose":[145,250,342,442],"expansion":[146],"(NCT03144245).":[147],"key":[149],"inclusion/exclusion":[150],"criteria":[151],"are:":[152],"adults":[153],"relapsed":[155],"and/or":[156,263],"refractory":[157],"AML":[158,262],"after":[159],"1\u20132":[160],"prior":[161,177,282,290],"induction":[162],"regimens":[163],"(with":[164],"standard":[166],"anthracycline\u2010based":[167],"regimen":[168,284],"hypomethylating":[170],"agent)":[171],"more":[174],"than":[175],"2":[176,345],"salvage":[178,283],"regimens.":[179],"administered":[182],"continuous":[184],"intravenous":[185],"infusion":[186],"(CIV)":[187],"for":[188,317,324,517],"14":[189],"consecutive":[190],"days":[191,390],"in":[192,248,349,378,400,433,465,478,510],"28":[194,313],"day":[195],"cycle.":[196],"Responding":[197],"patients":[198,231,258,268,275,295,314,321],"eligible":[200],"receive":[202],"additional":[203],"cycles":[204],"until":[205],"progression":[207],"unacceptable":[209],"toxicity.":[210],"concentrations":[214,452,512],"measured":[216],"validated":[218],"immunoassays":[219],"performed":[223],"flow":[225],"cytometry.":[226],"Results:":[227],"To":[228],"date,":[229],"30":[230,382,389],"(16":[232],"male/14":[233],"female)":[234],"median":[237],"age":[238],"72":[240],"years":[241],"(range":[242],"24\u201384":[243],"years)":[244],"have":[245],"been":[246,364,374],"enrolled":[247],"8":[249],"cohorts":[251],"from":[252],"0.5":[253],"200":[255,354],"mcg/day.":[256],"Twenty\u2010two":[257],"(73%)":[259],"had":[260,277,288,298],"adverse":[264,334],"cytogenetics,":[265],"including":[266,293],"9":[267,294,379,436],"(30%)":[269,296,380],"p53":[272],"mutation.":[273],"Nineteen":[274],"(63%)":[276,402],"received":[278,289,299],"at":[279,353],"least":[280],"18":[286],"(60%)":[287],"intensive":[291],"chemotherapy,":[292],"who":[297],"high\u2010dose":[301],"(\u2265":[302],"g/m2)":[304],"cytarabine\u2010based":[305],"regimen.":[306],"At":[307,408],"time":[309],"analysis,":[312],"were":[315,322,337,398,431,471],"evaluable":[316,323,406,437],"safety":[318],"27":[320,404],"activity.":[325],"No":[326,384],"dose\u2010limiting":[327],"toxicity":[328],"treatment\u2010related":[330],"Grade":[331,344,358,369],"\u2265":[332],"3":[333,359,434],"events":[335],"(AE)":[336],"reported.":[338],"Using":[339],"lead\u2010in":[341],"regimen,":[343],"CRS":[346,362],"was":[347,441],"observed":[348,399,432,472],"patient":[351,385],"(treated":[352],"mcg/day)":[355],"higher":[361],"has":[363,373,386,501],"observed.":[365],"most":[367],"common":[368],"\u22653":[370],"treatment\u2010emergent":[371],"AE":[372],"febrile":[375],"neutropenia,":[376],"reported":[377],"patients.":[383,407,438],"died":[387],"within":[388],"treatment":[392],"initiation.":[393],"Bone":[394],"marrow":[395],"blast":[396],"reductions":[397],"17":[401],"efficacy":[405],"doses":[409],"100":[411],"mcg":[412],"higher,":[414],"objective":[415],"responses":[416],"(1":[417],"complete":[418],"response":[419],"[CR],":[420],"CR":[422],"incomplete":[424],"hematologic":[425],"recovery,":[426],"partial":[429],"response)":[430],"PK":[440,504],"proportional":[443],"terminal":[446],"half\u2010life":[447],"2\u20133":[449],"days.":[450,462],"Serum":[451],"increased":[453],"gradually,":[454],"times":[456],"steady\u2010state":[458],"concentration":[459],"3\u20137":[461],"Marked":[463],"increases":[464],"serum":[466],"IL6,":[467],"IL8,":[468],"IL10":[470],"evidence":[474],"blood":[480],"bone":[482],"marrow.":[483],"Summary/Conclusion:":[484],"well\u2010tolerated":[487],"demonstrates":[489],"through":[492],"engagement":[494],"using":[495],"14\u2010day":[497],"administration":[498],"schedule.":[499],"unique":[503],"profile":[505],"gradual":[508],"increase":[509],"drug":[511],"thus":[514],"potential":[516],"better":[518],"controlled":[519],"activation.":[521]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1}],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2019-06-27T00:00:00"}